Volume 8, Issue 10, Pages (October 2009)

Slides:



Advertisements
Similar presentations
10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial 颈动脉内膜切除术无症状狭窄 多中心随机试验.
Advertisements

Volume 376, Issue 9753, Pages (November 2010)
Volume 370, Issue 9586, Pages (August 2007)
Prediction and Prevention of Stroke in Patients with Symptomatic Carotid Stenosis: The High-risk Period and the High-risk Patient  P.M. Rothwell  European.
Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of.
Volume 355, Issue 9212, Pages (April 2000)
Volume 385, Issue 9986, Pages (June 2015)
Volume 376, Issue 9747, Pages (October 2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials  Cholesterol.
Volume 11, Issue 4, Pages (April 2012)
Volume 16, Issue 9, Pages (September 2015)
Volume 9, Issue 4, Pages (April 2010)
Volume 376, Issue 9734, Pages (July 2010)
Volume 17, Issue 2, Pages (February 2016)
Volume 373, Issue 9679, Pages (June 2009)
Volume 388, Issue 10059, Pages (November 2016)
Volume 384, Issue 9958, Pages (November 2014)
Volume 11, Issue 6, Pages (June 2012)
Volume 384, Issue 9958, Pages (November 2014)
Meta-analysis of randomised controlled trials
Volume 388, Issue 10059, Pages (November 2016)
Volume 12, Issue 1, Pages (January 2013)
Volume 376, Issue 9734, Pages (July 2010)
Volume 376, Issue 9746, Pages (September 2010)
Volume 385, Issue 9967, Pages (February 2015)
Volume 382, Issue 9891, Pages (August 2013)
Volume 12, Issue 9, Pages (September 2013)
Aspirin in the prevention of cancer – Author's reply
Volume 14, Issue 12, Pages (December 2015)
George E. Kikano, MD, Marie T. Brown, MD  Mayo Clinic Proceedings 
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials  Cholesterol.
Volume 373, Issue 9679, Pages (June 2009)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta- analysis of individual participant data from randomised trials 
Volume 17, Issue 7, Pages (July 2018)
Volume 9, Issue 7, Pages (July 2010)
Differential outcomes of carotid stenting and endarterectomy performed exclusively by vascular surgeons in the Carotid Revascularization Endarterectomy.
Volume 379, Issue 9834, Pages (June 2012)
Volume 9, Issue 9, Pages (September 2010)
Ali F. AbuRahma, MD  Journal of Vascular Surgery 
Meta-analysis of randomised controlled trials
Volume 12, Issue 6, Pages (June 2013)
Volume 15, Issue 1, Pages (January 2014)
Volume 15, Issue 9, Pages (August 2016)
Silent embolic infarcts on computed tomography brain scans and risk of ipsilateral hemispheric events in patients with asymptomatic internal carotid artery.
Volume 17, Issue 7, Pages (July 2018)
Volume 376, Issue 9753, Pages (November 2010)
Volume 379, Issue 9834, Pages (June 2012)
Volume 371, Issue 9627, Pages (May 2008)
Volume 378, Issue 9786, Pages (July 2011)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials  Cholesterol.
Volume 382, Issue 9894, Pages (August 2013)
Volume 8, Issue 5, Pages (May 2009)
Volume 375, Issue 9726, Pages (May 2010)
Volume 375, Issue 9719, Pages (March 2010)
Volume 12, Issue 8, Pages (August 2013)
ACST: which subgroups will benefit most from carotid endarterectomy?
Volume 11, Issue 1, Pages (January 2010)
Volume 373, Issue 9672, Pages (April 2009)
Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study  Sarah.
Volume 376, Issue 9747, Pages (October 2010)
Safety of endovascular treatment of carotid artery stenosis compared with surgical treatment: A meta-analysis  Peter A. Ringleb, MD, Gilles Chatellier,
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28.
Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised.
Volume 8, Issue 10, Pages (October 2009)
Volume 388, Issue 10042, Pages (July 2016)
Timing and frequency of complications after carotid artery stenting: what is the optimal period of observation?  Kong T Tan, FRCS, FRCR, Trevor J Cleveland,
Volume 14, Issue 7, Pages (June 2013)
M. Hassan Murad, MD, MPH, David N. Flynn, BS, Mohamed B
Volume 373, Issue 9680, Pages (June 2009)
Volume 17, Issue 2, Pages (February 2016)
Presentation transcript:

Volume 8, Issue 10, Pages 898-907 (October 2009) Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial  Jörg Ederle, MD, Leo H Bonati, MD, Joanna Dobson, MSc, Roland L Featherstone, PhD, Peter A Gaines, FRCR, Jonathan D Beard, FRCS, Graham S Venables, FRCP, Hugh S Markus, FRCP, Andrew Clifton, FRCR, Peter Sandercock, FRCP, Martin M Brown, FRCP  The Lancet Neurology  Volume 8, Issue 10, Pages 898-907 (October 2009) DOI: 10.1016/S1474-4422(09)70228-5 Copyright © 2009 Elsevier Ltd Terms and Conditions

Figure 1 Trial profile The Lancet Neurology 2009 8, 898-907DOI: (10.1016/S1474-4422(09)70228-5) Copyright © 2009 Elsevier Ltd Terms and Conditions

Figure 2 Kaplan–Meier estimates of cumulative incidence The numbers above and below the lines refer to the 8-year incidence (SE) (%). (A) Disabling stroke or death (primary outcome measure). (B) Any stroke or perioperative death. (C) Stroke that lasted more than 7 days or perioperative death within 30 days of treatment. (D) Non-perioperative stroke or TIA. (E) Non-perioperative stroke. (F) Non-perioperative ipsilateral stroke or transient ischaemic attack. (G) Non-perioperative ipsilateral stroke. (H) Any cause of death. Except where stated, stroke refers to events in any territory. A, B, C, and H are analysed from date of randomisation; D and G are analysed from 30 days after treatment. No stroke that occurred more than 30 days after treatment lasted for fewer than 7 days. The Lancet Neurology 2009 8, 898-907DOI: (10.1016/S1474-4422(09)70228-5) Copyright © 2009 Elsevier Ltd Terms and Conditions

Figure 3 Subgroup analysis to compare the rates of the outcome event of stroke in any territory that lasted more than 7 days or perioperative death, according to various baseline characteristics p values are associated with treatment–covariate interaction tests. The dotted vertical line is the hazard ratio in the overall population. Analyses are by intention to treat. n=number of events. N=number of patients in each group. EVT=endovascular treatment. CEA=carotid endarterectomy. HR=hazard ratio. TIA=transient ischaemic attack. MI=myocardial infarction. The Lancet Neurology 2009 8, 898-907DOI: (10.1016/S1474-4422(09)70228-5) Copyright © 2009 Elsevier Ltd Terms and Conditions

Figure 4 Meta-analysis of the main multicentre randomised controlled trials Comparison of long-term benefit of endovascular treatment versus endarterectomy for symptomatic carotid artery stenosis in prevention of non-perioperative ipsilateral stroke. The summary estimate statistic is a Peto odds ratio (fixed-effect model), the centre of the diamond is the point estimate, and the ends of the line are the 95% CI. The I-square statistic gives an indication of heterogeneity, where 0% suggests that it might not be important. The value of I-squared depends on the magnitude and direction of effects and the strength of evidence for heterogeneity (p value from χ2 test). The Lancet Neurology 2009 8, 898-907DOI: (10.1016/S1474-4422(09)70228-5) Copyright © 2009 Elsevier Ltd Terms and Conditions